eXoZymes develops enzyme-based biomanufacturing solutions that use AI-enhanced, cell-free enzyme systems.
eXoZymes has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in June 2026.
eXoZymes's investors include National Science Foundation, US Department of Energy, U.S. Department of War, National Institutes of Health, National Institute of General Medical Science.
eXoZymes is headquartered in Monrovia, United States.
eXoZymes develops enzyme-based biomanufacturing solutions that use AI-enhanced, cell-free enzyme systems.
eXoZymes is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"eXoZymes — Funding & Investors." VCBacked, June 25, 2026, https://www.vcbacked.co/company/exozymes. Accessed July 20, 2026.
VCBacked. (2026). eXoZymes — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/exozymes
{{cite web |title=eXoZymes — Funding & Investors |url=https://www.vcbacked.co/company/exozymes |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated